COMP <GO>
UG vs YCBD // EV/EBITDA & P/E VALUATION
United-Guardian Inc. (NASDAQ) VS. cbdMD Inc. (NYSE) • 15-METRIC TALLY: UG 4
— YCBD 0
■ METRIC PARITY
LAST: $6.66 (-1.19%) • MKT CAP: $30.6M
valuation
12.8x
LAST: $0.39 (+4.56%) • MKT CAP: $4.3M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (UG VS. YCBD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | UG | YCBD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 62.40% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 17.80% | -30.40% | +48.20 | UG | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 12.8x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 6.24% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -11.30% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -10.60% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | -1.50% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 9.04% | 0.00% | +9.04 | UG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 4/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.1 | 44.1 | +12.98 | UG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 13.5x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $30.6M | $4.3M | $26.3M | UG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | UG REV | YCBD REV | UG GROSS % | YCBD GROSS % | UG FCF | YCBD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $19.2M | — | 62.4% | $1.9M | -$1.6M |
| FY 2024 | $0 | $19.5M | — | 61.6% | $3.0M | -$542.8K |
| FY 2023 | $0 | $24.2M | — | — | $3.1M | -$4.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
UG // BETA —
YCBD // BETA —